Company / Tangible Book Value per Share
Olema Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.96
FY2024
5-year range
$4.94 / $48.16
FY2020-FY2024
Trend
+24.1%
vs FY2023
Sector context
#76 of 209
Health Care
What the data says
At $6.96, Olema Pharmaceuticals, Inc.'s tangible book value per share ranks #76 of 209 in the Health Care sector. Improved from $4.94 to $6.96 over the past 2 years.
Based on SEC 10-K filings.
6.96 in FY2024 with a 3-year CAGR of -1.1%.
Improved from $4.94 to $6.96 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 209 in Health CareTop 36% of 209This company $6.96 Sector average $93.47
▼
-92.6% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 24.1% year-over-year.
- Ranks #76 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.96 | +24.1% |
| FY2023 | $5.61 | +13.6% |
| FY2022 | $4.94 | -31.4% |
| FY2021 | $7.20 | -85.0% |
| FY2020 | $48.16 | +1278.9% |
| FY2019 | -$4.09 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026